The Novonix share price just rebounded 13%. Is it a buy?

Novonix has had a very volatile day. Is the company worth buying?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Novonix share price has surged 13% today after hitting a 52-week low
  • However, it’s still down around 60% since the beginning of the year
  • The company continues to make business progress

The Novonix Ltd (ASX: NVX) share price is experiencing high levels of volatility.

Earlier today, the battery materials and technology company dropped as much as 11% to around $3.60. However, it has since rebounded 13% from that 52-week low. It's now 0.25% in the green at $4.07.

The S&P/ASX 200 Index (ASX: XJO) is suffering from elevated selling by investors at the moment. There is a lot of market focus on high inflation and the potential of rising interest rates.

At the time of writing, the ASX 200 is down by 1.14%. But, who knows what is going to happen next?

A man in business suit wearing old fashioned pilot's leather headgear, goggles and scarf bounces on a pogo stick in a dry, arid environment with nothing else around except distant hills in the background.

Image source: Getty Images

Is the Novonix share price an opportunity?

While Novonix may have regained the lost ground of the day, it is still down significantly over longer timeframes. Over the past month, Novonix shares have fallen by 35% and since the start of the year, the Novonix share price has fallen by around 60%.

The broker Morgans currently has a rating of 'hold' on the business, with a price target of $4.88. That implies a possible rise of around 20%. Morgans noted that the cost of the recent listing onto the NASDAQ of a few million dollars was a one-off, which impacted its earnings. The business started trading on the NASDAQ at the start of February 2022.

Operational progress

One of the recent highlights from the company earlier this year was the closed anode material supply agreement and strategic investment in US-based KORE Power. Novonix will be the exclusive supplier of graphite anode material to KORE Power's US operations. Novonix agreed to invest US$25 million for an approximate 5% stake in KORE Power. The deliveries will start in 2024.

It is continuing to engage with Samsung SDI and Sanyo and other tier 1 cell and automotive manufacturers for capacity planning for the next production facility.

A technology development agreement was signed with Phillips 66 to leverage both parties' expertise to collaborate on "the development and optimisation of feedstock and anode processing with the goal of higher performance, lower carbon intensity materials".

It also said that it's continuing to engage and progress relationships with multiple international companies for potential technology partnership opportunities and monitor clean energy policies in North America and Europe.

In terms of the battery technology solutions activities, it said it has seen continued strong revenue growth each quarter with expansion of hardware sales and research and development service offerings by adding and growing key strategic accounts.

With the Emera energy storage system project, it is assembling four full-scale pack prototype systems for testing with Emera.

Regarding the cathode synthesis technology activities, it said it has been expanding its internal cathode development team and capabilities.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Lows

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

a woman sits next to her computer screen with her head in her hands with the screens slowing graphs on downward trajectories.
52-Week Lows

Can the beaten-down CSL share price ever reach $300 again?

CSL is near decade lows. Can it ever climb back?

Read more »

A stressed businessman sits next to his briefcase with his head in his hands, while the ASX boards behind him show shares crashing.
52-Week Lows

CSL's collapse deepens. Why this ASX giant can't find a floor

CSL shares hit a 9-year low as new demand concerns emerge.

Read more »

Unsure man analysing data on laptop.
52-Week Lows

Down 50% in the past year, are these ASX 200 shares too cheap to ignore?

These stocks have recently recovered from yearly lows.

Read more »

Lines of codes and graphs in the background with woman looking at laptop trying to understand the data.
52-Week Lows

These 3 ASX 200 stocks hit a 52-week low: Buy, sell or hold?

These shares have all tumbled in value this year.

Read more »

Person with thumbs down and a red sad face poster covering their face.
52-Week Lows

Harvey Norman just hit a 52-week low. Is this beaten-down ASX retailer becoming too cheap to ignore?

Harvey Norman sinks to 52-week low as sentiment weakens further.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
52-Week Lows

Down 43% this year, this ASX tech stock is now back at January 2025 levels

Megaport shares are down 43% this year as weak momentum continues.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
52-Week Lows

Which of these ASX stocks near 52-week lows is worth buying?

Is there any value for these beaten-down shares?

Read more »